Forum: Schneeberger on Clavien

https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/c1/fa/37/c1fa371b-d8e9-3cf6-0031-dd0ad2e0662e/mza_14851455372299837377.jpg/600x600bb.jpg

First Rounders

Nature Biotechnology

61 episodes

11 months ago

Nature Biotechnology's First Rounders podcast is a series of conversations with founders, financers and developers from biotech's past, present and future.

Hosted on Acast. See acast.com/privacy for more information.

Natural Sciences

RSS

All content for First Rounders is the property of Nature Biotechnology and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Nature Biotechnology's First Rounders podcast is a series of conversations with founders, financers and developers from biotech's past, present and future.

Hosted on Acast. See acast.com/privacy for more information.

Natural Sciences

https://assets.pippa.io/shows/61b9b44742e8562fa5985771/61b9b4a85ca4d10013ea6293.png

Forum: Schneeberger on Clavien

First Rounders

22 minutes 20 seconds

5 years ago

Forum: Schneeberger on Clavien

Senior Editor Irene Jarchum talks to Stefan Schneeberger about the significance of a recent Nature Biotechnology paper describing a sophisticated perfusion machine to keep human livers alive for a week. The work was carried out by Pierre-Alain Clavien and colleagues from ETH Zurich. Read the paper here.

Hosted on Acast. See acast.com/privacy for more information.